| The Effect of Beta-glucan in Non-Small Cell Lung Cancer (NCT00682032) | University of Louisville | 2008-10-01 |
| A Study of Avastin (Bevacizumab) in Combination With Carboplatin-Based Chemotherapy in Patients With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer. (NCT00700180) | Hoffmann-La Roche | 2008-09-01 |
| Efficacy and Safety Study of ZOMETA® in Treatment of High-level NTX Non Small Cell Lung Cancer With Bone Metastasis (NCT00762346) | Sun Yat-sen University | 2008-09-01 |
| Evaluation of Preoperative Endobronchial Ultrasound (EBUS) in Non Small Cell Lung Cancer (NSCLC) (NCT00960271) | University Hospital, Rouen | 2008-09-01 |
| A Non-interventional Trial of Erlotinib (Tarceva) Metastatic Non-small Cell Lung Cancer (NCT02595450) | Hoffmann-La Roche | 2008-09-01 |
| Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer (NCT00686959) | Eli Lilly and Company | 2008-09-01 |
| Identification of EGFR-TKIs Sensitivity or Resistance Markers in NSCLC May Help in Optimal Patient Selection (NCT00831454) | Armando Santoro, MD | 2008-09-01 |
| A Randomized Phase 2 Study of Erlotinib + ARQ 197 Versus Erlotinib + Placebo in Previously Treated Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) (NCT00777309) | ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) | 2008-09-01 |
| Phase II Study of Dasatinib in Previously Treated Patients With Advanced NSCLC (NCT00787267) | Duke University | 2008-09-01 |
| FDG-PET Scan Response Guided Chemotherapy Strategy for Advanced Non-small Cell Lung Cancer (NCT01170923) | Asan Medical Center | 2008-09-01 |
| Evaluation of Stents to Open Restricted Airways in Patients With Centrally Placed Non-small Cell Lung Cancer (NCT01003522) | Royal Marsden NHS Foundation Trust | 2008-09-01 |
| Safety Study of XL147 (SAR245408), in Combination With Paclitaxel and Carboplatin in Adults With Solid Tumors (NCT00756847) | Sanofi | 2008-09-01 |
| Ixabepilone and Carboplatin +/- Bevacizumab in Advanced Non-Small-Cell Lung Cancer (NCT00741988) | SCRI Development Innovations, LLC | 2008-09-01 |
| Dose-Escalation Study of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed to Treat Advanced Solid Tumors (NCT00743379) | Threshold Pharmaceuticals | 2008-08-01 |
| ZD4054 (Zibotentan) Phase II Non-Small Cell Lung Cancer Study (NCT00745875) | AstraZeneca | 2008-08-01 |
| Erlotinib Versus Gemcitabine/Carboplatin in Chemo-naive Stage IIIB/IV Non-Small Cell Lung Cancer Patients With Epidermal Growth Factor Receptor (EGFR) Exon 19 or 21 Mutation (NCT00874419) | Tongji University | 2008-08-01 |
| Using FDG-PET During Radiation Therapy in Non-Small Cell Lung Cancer (NCT01190527) | University of Michigan Rogel Cancer Center | 2008-08-01 |
| Safety Study of XL765 (SAR245409) in Combination With Erlotinib in Adults With Solid Tumors (NCT00777699) | Sanofi | 2008-08-01 |
| Pioglitazone to Treat Adults Undergoing Surgery for Non-small Cell Lung Cancer (NCT00923949) | National Cancer Institute (NCI) | 2008-08-01 |
| Non-small Cell Lung Cancer and Quality of Life (NCT00818402) | University of Turku | 2008-08-01 |
| A Phase 2 Exploratory Study of Erlotinib and SNDX-275 in Participants With Non-small Cell Lung Carcinoma Who Are Progressing on Erlotinib (NCT00750698) | Syndax Pharmaceuticals | 2008-08-01 |
| Screening Non Small Cell Lung Cancer With Bone Metastasis and Efficacy and Safety Research of Receiving Bisphosphonates (NCT00765687) | Sun Yat-sen University | 2008-08-01 |
| Study for Therapy of Locally Advanced or Metastatic Non Small Cell Lung Cancer (NSCLC) With Cisplatin / Docetaxel or Oxaliplatin / Docetaxel (NCT01222312) | Krankenhaus Nordwest | 2008-08-01 |
| Combination of Erlotinib and Bevacizumab as Second-line Treatment in Patients With Non-small Cell Lung Cancer (NCT00749567) | Hellenic Oncology Research Group | 2008-07-01 |
| Trastuzumab Therapy in Non-Small Cell Lung Cancer Patients (NCT00758134) | Armando Santoro, MD | 2008-07-01 |
| A Study of Pemetrexed Plus Carboplatin Combined With Radiation in Patients With Inoperable Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC) (RT0801) (NCT00886678) | Zhejiang Cancer Hospital | 2008-07-01 |
| Effect of Talactoferrin in Adults With Non-Small Cell Lung Cancer (NCT00923741) | National Cancer Institute (NCI) | 2008-06-19 |
| Study of Bavituximab Plus Paclitaxel and Carboplatin in Patients With Non-Small Cell Lung Cancer (NCT00687817) | Peregrine Pharmaceuticals | 2008-06-01 |
| Pemetrexed Plus Bevacizumab in Non Small Cell Lung Cancer (NCT00741221) | Hellenic Oncology Research Group | 2008-06-01 |
| Study of Combination of Metronomic Oral Vinorelbine and Sorafenib in Patients With Advanced Non-small Cell Lung Cancer (NCT00870532) | National Cancer Centre, Singapore | 2008-06-01 |
| A Trial of Paclitaxel (Genexol®) and Cisplatin Versus Paclitaxel Loaded Polymeric Micelle (Genexol-PM®) and Cisplatin in Advanced Non Small Cell Lung Cancer (NCT01023347) | Samyang Biopharmaceuticals Corporation | 2008-06-01 |
| A Study of Mycobacterium w in Combination With Paclitaxel Plus Cisplatin in Advanced Non Small Cell Lung Cancer (NCT00680940) | Cadila Pharnmaceuticals | 2008-06-01 |
| Enoxaparin Low Molecular Weight Heparin (LMWH) in Advanced Non Small Cell Lung Cancer: Effect on Survival and Symptom Control in Patients Undergoing First Line Chemotherapy (SYRINGES) (NCT00771563) | University Hospital, Antwerp | 2008-06-01 |
| Safety Study of XL647 and XL147 Administered in Combination Daily in Adults With Solid Tumors (NCT00704392) | Exelixis | 2008-06-01 |
| Asymptomatic Brain Metastasis in Non-small Cell Lung Cancer (NSCLC) (NCT01130766) | Samsung Medical Center | 2008-06-01 |
| PET CT Re-Planning NSCLC (4DCT-PET) (NCT03403127) | University Health Network, Toronto | 2008-05-20 |
| Open Label Trial of Perifosine in Patients Currently Being Treated on Perifosine Trials in Solid Tumors or Multiple Myeloma (NCT00847366) | AEterna Zentaris | 2008-05-01 |
| Phase I/II of Oral Vorinostat Combination With Erlotinib in NSCLC Patients With EGFR Mutations With DP After Erlotinib. (NCT00503971) | Spanish Lung Cancer Group | 2008-05-01 |
| Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Non-Small Cell Lung Cancer (NCT00674258) | Tokyo University | 2008-05-01 |
| Mutations in the Epidermal Growth Factor Receptor(EGFR) Gene in Non-Small Cell Lung Carcinoma (NSCLC) and the Relation to Response of Treatment With Erlotinib (NCT00815971) | Aarhus University Hospital | 2008-05-01 |
| Safety Study of XL147 (SAR245408) in Combination With Erlotinib in Adults With Solid Tumors (NCT00692640) | Sanofi | 2008-05-01 |
| Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Non-Small Cell Lung Cancer (NCT00673777) | Tokyo University | 2008-05-01 |
| Pemetrexed (ALIMTA) and Gefitinib (IRESSA®) in Never-Smoker and Adenocarcinoma Patients With Non-Small Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy (NCT01066195) | Samsung Medical Center | 2008-05-01 |
| NovoTTF-100L in Combination With Pemetrexed (Alimta®) for Advanced Non-small Cell Lung Cancer (NCT00749346) | NovoCure Ltd. | 2008-05-01 |
| Study to Evaluate KOS-1584 in Patients With Advanced or Metastatic Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) (NCT00651508) | Bristol-Myers Squibb | 2008-04-01 |
| Study of Vandetanib Combined With Chemotherapy to Treat Advanced Non-small Cell Lung Cancer (NCT00687297) | PrECOG, LLC. | 2008-04-01 |
| ASA404 or Placebo in Combination With Paclitaxel and Carboplatin as First-Line Treatment for Stage IIIb/IV Non-Small Cell Lung Cancer (NCT00662597) | Novartis Pharmaceuticals | 2008-04-01 |
| The Effect of Berries on Lung Cancer Tumors (NCT00681512) | University of Louisville | 2008-04-01 |
| Concurrent Chemoradiotherapy (CCRT) With Paclitaxel Plus Cisplatin in LA Non-small-cell Lung Cancer (NSCLC) (NCT00686322) | Taipei Veterans General Hospital, Taiwan | 2008-04-01 |
| Study of Oral Vinorelbine and Erlotinib in Non-Small Cell Lung Cancer (NCT00702182) | National Cancer Centre, Singapore | 2008-04-01 |
| Carboplatin, Abraxane, and Bevacizumab in Previously Untreated Patients With Advanced Non-Small Cell Lung Cancer (NCT00642759) | Massachusetts General Hospital | 2008-04-01 |
| Carboplatin, Paclitaxel, Bevacizumab and Vorinostat for Patients With Advanced Non-Small Cell Lung Cancer (NCT00702572) | Milton S. Hershey Medical Center | 2008-04-01 |
| Docetaxel Plus Bevacizumab in Metastatic Non Small Cell Lung Cancer (NCT00741195) | Hellenic Oncology Research Group | 2008-04-01 |
| An Open-label, Phase I Trial of Intravenous ASA404 Administered in Combination With Paclitaxel and Carboplatin in Japanese Patients With Non-Small Cell Lung Cancer (NSCLC) (NCT00674102) | Novartis Pharmaceuticals | 2008-04-01 |
| A Phase 1b Study With Volociximab in Combination With Carboplatin, Paclitaxel, and Bevacizumab in First-line, Advanced Non-small Cell Lung Cancer (NSCLC) (NCT00666692) | Abbott | 2008-04-01 |
| Early Prediction of Therapeutic Response to Targeted Therapy in Stage IIIB/IV or Recurrent Lung Cancer Patients (NCT00708448) | University of Utah | 2008-03-28 |
| Efficacy of Erlotinib for Brain Metastasis of Non-Small Cell Lung Cancer (NCT00663689) | Guangdong Provincial People's Hospital | 2008-03-01 |
| Pemetrexed Followed by Docetaxel or in Reverse Sequence (NCT01442909) | Taipei Veterans General Hospital, Taiwan | 2008-03-01 |
| Gemcitabine and Carboplatin for Elderly Patient With Lung Cancer (NCT00881296) | Hamamatsu University | 2008-03-01 |
| Sorafenib and Erlotinib or Sorafenib Alone in Advanced Non-Small Cell Lung Cancer Progressing on Erlotinib (NCT00609804) | SCRI Development Innovations, LLC | 2008-03-01 |
| NPI-0052 and Vorinostat in Patients With Non-small Cell Lung Cancer, Pancreatic Cancer, Melanoma or Lymphoma (NCT00667082) | Celgene | 2008-03-01 |
| Lower Dose Chemotherapy Given More Frequent With Avastin to Treat Advanced Non-Squamous Non-Small Cell Lung Cancer (NCT00655850) | University of Alabama at Birmingham | 2008-03-01 |
| Study to Evaluate RAD001 in Combination With Radiotherapy in Non-small Cell Lung Cancer (NCT01167530) | Gustave Roussy, Cancer Campus, Grand Paris | 2008-02-26 |
| Individualized Therapy Based of Tumoral mRNA Levels of ERCC1, RRM1 and BRCA1 in Advanced Non-Small-Cell Lung Cancer (NCT00705549) | Hellenic Oncology Research Group | 2008-02-01 |
| Study to Evaluate Treatment Customized According to RAP80 and BRCA1 in Patients With Advanced Lung Carcinoma (NCT00617656) | Spanish Lung Cancer Group | 2008-02-01 |
| Detection of EGFR Mutations in the Blood of Patients With Non-small Cell Lung Cancer: a Feasibility Study (NCT00717002) | National University Hospital, Singapore | 2008-02-01 |
| Sorafenib/Erlotinib Versus Erlotinib Alone in Previously Treated Advanced Non-Small-Cell Lung Cancer (NSCLC) (NCT00600015) | SCRI Development Innovations, LLC | 2008-02-01 |
| A Study for Patients With Non-Squamous Non-Small Cell Lung Cancer (NCT00609518) | Eli Lilly and Company | 2008-02-01 |
| Optimization of Treatment of Advanced Nonsmall Cell Lung Cancer Using Radiotherapy and Chemotherapy (NCT00864331) | International Atomic Energy Agency | 2008-02-01 |
| A Phase 1b/2 Study of AMG 655 in Combination With Paclitaxel and Carboplatin for the First-Line Treatment of Advanced Non-Small Cell Lung Cancer (NCT00534027) | Amgen | 2008-01-01 |
| A Study of BMS-663513 in Combination With Chemoradiation in Subjects With Non Small Cell Lung Carcinoma (NSCLC) (NCT00461110) | Bristol-Myers Squibb | 2008-01-01 |
| A Study of Tarceva (Erlotinib) in Combination With Avastin (Bevacizumab) in Patients With Advanced Non-Small Cell Lung Cancer. (NCT00531960) | Hoffmann-La Roche | 2008-01-01 |
| Utility of Routine Cervical Mediastinoscopy in Clinical Stage I Non-Small Cell Lung Cancer (NSCLC) (NCT01146366) | Jennifer Bell | 2008-01-01 |
| A Study Comparing of Two Different Chemotherapy Regimens, in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer (NCT00606021) | Eli Lilly and Company | 2008-01-01 |
| Study of Polyphenon E in Addition to Erlotinib in Advanced Non Small Cell Lung Cancer (NCT00707252) | Louisiana State University Health Sciences Center Shreveport | 2008-01-01 |
| Study of Low Dose Chemotherapy Plus Sorafenib as Initial Therapy for Patients With Advanced Non-Squamous Cell NSCLC (NCT00801801) | Francisco Robert,MD | 2008-01-01 |
| Cisplatin/Vinorelbine/Bevacizumab Followed by Docetaxel/Gemcitabine/Bevacizumab Versus the Cisplatin/Docetaxel/Bevacizumab Combination in Locally Advanced or Metastatic NSCLC (NCT00620971) | Hellenic Oncology Research Group | 2008-01-01 |
| Phase II Study of Stereotactic Body Radiation Therapy Using Tomotherapy for Tumors of the Lung (NCT00832780) | New Mexico Cancer Research Alliance | 2008-01-01 |
| Study of Pralatrexate vs. Erlotinib for Non-Small Cell Lung Cancer After at Least 1 Prior Platinum-based Treatment (NCT00606502) | Spectrum Pharmaceuticals, Inc | 2008-01-01 |
| Carboplatin, Docetaxel, Bevacizumab, and Erlotinib Versus Chemotherapy Alone in Resected NSCLC (NCT00621049) | SCRI Development Innovations, LLC | 2007-12-01 |
| Erlotinib in Patients With Resected, Early Stage NSCLC With Confirmed Mutations in the EGFR (NCT00567359) | Massachusetts General Hospital | 2007-12-01 |
| Efficacy of Gefitinib for Brain Metastasis of Non-Small Cell Lung Cancer (NCT00614809) | Guangdong Provincial People's Hospital | 2007-12-01 |
| A Phase 1b Study With Volociximab in Combination With Carboplatin and Paclitaxel in First-line, Advanced Non-Small Cell Lung Cancer (NSCLC) (NCT00654758) | AbbVie | 2007-12-01 |
| Retrospective Study Evaluating IGF1R And p95HER2 as Prognostic Factors in Non Small Cell Lung Cancer (NSCLC) (NCT00763607) | Armando Santoro, MD | 2007-11-01 |
| Erlotinib and Chemotherapy for Patients With Stage IB-IIIA NSCLC With EGFR Mutations (ECON) (NCT00577707) | Memorial Sloan Kettering Cancer Center | 2007-11-01 |
| Safety of Adding IMO-2055 to Erlotinib + Bevacizumab in 2nd Line Treatment for Patients With NSCLC (NCT00633529) | EMD Serono | 2007-11-01 |
| A Phase I Study of SUNITINIB and Rapamycin in Advanced Non-Small Cell Lung Cancer (NSCLC) (NCT00555256) | Washington University School of Medicine | 2007-11-01 |
| A Study for Non-Smoker Patients With Nonsquamous Non-Small Cell Lung Cancer (NCT00550173) | Eli Lilly and Company | 2007-11-01 |
| TARCEVA (Erlotinib) in Combination With Chemoradiation in Patients With Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC) (NCT00563784) | M.D. Anderson Cancer Center | 2007-11-01 |
| Erlotinib and Sorafenib in Chemonaive Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer (NCT00722969) | Universitair Ziekenhuis Brussel | 2007-11-01 |
| Carboplatin, Bevacizumab and Pemetrexed in Advanced Non Small Cell Lung Cancer (NCT00614822) | Christiana Care Health Services | 2007-11-01 |
| Phase II Study of Sorafenib + Carboplatin and Docetaxel in First Line Treatment of Stage IIIB/IV NSCLC (NCT00647426) | Abramson Cancer Center at Penn Medicine | 2007-11-01 |
| CAPPA-2: Cisplatin Added to Gemcitabine in Poor Performance Advanced NSCLC Patients (NCT00526643) | National Cancer Institute, Naples | 2007-11-01 |
| A Study of Management of Tarceva - Induced Rash in Patients With Non-Small Cell Lung Cancer. (NCT00531934) | Hoffmann-La Roche | 2007-10-01 |
| Study of Pemetrexed + Carboplatin + Bevacizumab + Enzastaurin Versus Pemetrexed + Carboplatin + Bevacizumab + Placebo in Participants With Non-Small Cell Lung Cancer Who Have Not Been Previously Treated With Chemotherapy (NCT00533429) | Eli Lilly and Company | 2007-10-01 |
| Phase 1 Study of TG01 and Erlotinib in Non-small Cell Lung Cancer (NCSLC) Patients (NCT00569114) | Tragara Pharmaceuticals, Inc. | 2007-10-01 |
| Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer (NCT00520676) | Eli Lilly and Company | 2007-10-01 |
| Adjuvant Melatonin for Prevention of Lung Cancer Recurrence and Mortality (NCT00668707) | The Canadian College of Naturopathic Medicine | 2007-09-01 |
| Performance Status During Treatment With Pemetrexed in Patients With NSCLC (NCT00540241) | Eli Lilly and Company | 2007-09-01 |
| A Randomized Phase 2 Study of AT-101 in Combination With Docetaxel in Relapsed/Refractory Non-Small Cell Lung Cancer (NCT00544960) | Ascenta Therapeutics | 2007-09-01 |